Semi-synthetic strategies to obtain glucosylated MOG to identify antibodies as biomarkers in multiple sclerosis disease

Adv Exp Med Biol. 2009:611:327-8. doi: 10.1007/978-0-387-73657-0_146.

Authors

Francesca Gori¹, Barbara Mulinacci, Eva Bonchi, Mario Chelli, Francesco Lolli, Anna M Papini, Paolo Rovero

Affiliation

¹ Department of Pharmaceutical Sciences, University of Florence, Sesto Fiorentino, FL, Italy.

PMID: 19400213
DOI: 10.1007/978-0-387-73657-0_146

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antibodies / immunology*
Biomarkers / analysis*
Crystallography, X-Ray
Enzyme-Linked Immunosorbent Assay
Glycosylation
Humans
Multiple Sclerosis / immunology*
Myelin Proteins
Myelin-Associated Glycoprotein / chemical synthesis*
Myelin-Associated Glycoprotein / chemistry
Myelin-Associated Glycoprotein / immunology
Myelin-Associated Glycoprotein / metabolism
Myelin-Oligodendrocyte Glycoprotein

Substances

Antibodies
Biomarkers
MOG protein, human
Myelin Proteins
Myelin-Associated Glycoprotein
Myelin-Oligodendrocyte Glycoprotein